secwatch.observer — SEC 8-K summary
======================================

Issuer:     Envoy Medical, Inc. (COCH)
CIK:        0001840877
Form:       8-K
Filed at:   2025-05-01T23:59:59+00:00
Accession:  0001213900-25-038498
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Envoy Medical Q1 revenue down $13k; enrolls 10 in pivotal CI trial; secures $10M funding
--------------------------------------------------------------------------------

- Net revenues decreased $13k YoY to an undisclosed amount; cash balance $5.3M as of March 31, 2025.
- R&D expenses rose $400k YoY due to headcount and clinical study startup for Acclaim cochlear implant.
- Enrolled 10 participants in first stage of pivotal clinical trial for fully implanted Acclaim CI; 6 activated.
- Secured additional $10M in funding to advance pivotal clinical trial; no serious adverse events reported.
- Modifications appear to address electrical system noise observed in earlier feasibility study.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1840877/000121390025038498/0001213900-25-038498-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1840877/000121390025038498/ea0240479-8k_envoy.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-038498

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer